ivabradine has been researched along with Coronary Occlusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berdeaux, A; Bruneval, P; Chetboul, V; Couvreur, N; Ghaleh, B; Gouni, V; Mandet, C; Pons, S; Pouchelon, JL; Tissier, R | 1 |
| Ceconi, C; Ferrari, R; Ford, I; Fox, K; Freedman, SB; Gueret, P; Hildebrandt, P; McDonagh, T; Parrinello, G; Robertson, M; Steg, PG; Tardif, JC; Tendera, M | 1 |
1 trial(s) available for ivabradine and Coronary Occlusion
| Article | Year |
|---|---|
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL.
Topics: Aged; Benzazepines; Coronary Occlusion; Double-Blind Method; Female; Heart Rate; Humans; Ivabradine; Male; Ultrasonography; Ventricular Remodeling | 2011 |
1 other study(ies) available for ivabradine and Coronary Occlusion
| Article | Year |
|---|---|
Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression.
Topics: Animals; Anti-Arrhythmia Agents; Benzazepines; Blotting, Western; Calcium-Binding Proteins; Coronary Occlusion; Heart Rate; Ivabradine; Myocardial Infarction; Myocardial Reperfusion; Rabbits; Stroke Volume; Tacrolimus Binding Protein 1A; Ventricular Dysfunction, Left | 2010 |